United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
578.54
+0.91 (0.16%)
At close: Apr 14, 2026, 4:00 PM EDT
578.54
0.00 (0.00%)
After-hours: Apr 14, 2026, 5:37 PM EDT

United Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25,35621,26515,81810,34412,8019,741
Market Cap Growth
81.64%34.43%52.93%-19.20%31.41%44.27%
Enterprise Value
20,68218,34512,8518,05010,7628,610
Last Close Price
578.54487.25352.84219.89278.09216.08
PE Ratio
20.7317.4914.3211.1018.5421.48
Forward PE
20.3417.1412.179.9313.5713.45
PEG Ratio
1.984.431.0213.471.030.72
PS Ratio
7.966.685.504.446.615.78
PB Ratio
3.553.002.451.732.672.46
P/TBV Ratio
3.903.292.661.832.812.58
P/FCF Ratio
24.3520.4314.6413.8419.2920.40
P/OCF Ratio
16.2313.6211.9210.5815.9516.28
EV/Sales Ratio
6.505.764.473.465.565.11
EV/EBITDA Ratio
12.9211.628.876.5010.4414.21
EV/EBIT Ratio
13.6512.299.336.7910.9915.49
EV/FCF Ratio
19.8717.6311.8910.7716.2218.04
Debt / Equity Ratio
-00.050.120.170.20
Debt / EBITDA Ratio
--0.210.560.781.32
Debt / FCF Ratio
--0.280.941.211.68
Net Debt / Equity Ratio
-0.41-0.41-0.46-0.38-0.42-0.29
Net Debt / EBITDA Ratio
-1.85-1.85-2.05-1.85-1.98-1.87
Net Debt / FCF Ratio
-2.81-2.81-2.75-3.07-3.07-2.37
Asset Turnover
0.420.420.400.350.350.34
Inventory Turnover
2.252.252.302.411.551.36
Quick Ratio
5.835.834.804.078.916.97
Current Ratio
6.606.605.254.419.857.61
Return on Equity (ROE)
19.71%19.71%19.23%18.27%16.61%12.94%
Return on Assets (ROA)
15.25%15.25%14.72%13.86%13.37%9.10%
Return on Invested Capital (ROIC)
28.27%28.27%28.04%26.73%24.82%15.75%
Return on Capital Employed (ROCE)
21.41%21.41%21.20%19.64%18.55%12.14%
Earnings Yield
5.27%5.72%6.98%9.01%5.39%4.66%
FCF Yield
4.11%4.89%6.83%7.23%5.18%4.90%
Buyback Yield / Dilution
1.24%1.24%2.41%-2.47%-2.54%-6.05%
Total Shareholder Return
1.24%1.24%2.41%-2.47%-2.54%-6.05%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q